These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 15817913

  • 1. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men.
    Haijma SV, van Dam PS, de Vries WR, Maitimu-Smeele I, Dieguez C, Casanueva FF, Koppeschaar HP.
    Eur J Endocrinol; 2005 Apr; 152(4):575-80. PubMed ID: 15817913
    [Abstract] [Full Text] [Related]

  • 2. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
    Cordido F, Alvarez-Castro P, Isidro ML, Casanueva FF, Dieguez C.
    Eur J Endocrinol; 2003 Aug; 149(2):117-22. PubMed ID: 12887288
    [Abstract] [Full Text] [Related]

  • 3. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults.
    Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C, Obradovic S, Dieguez C, Casanueva FF.
    Lancet; 2000 Sep 30; 356(9236):1137-42. PubMed ID: 11030292
    [Abstract] [Full Text] [Related]

  • 4. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD.
    J Clin Endocrinol Metab; 2004 May 30; 89(5):2290-300. PubMed ID: 15126555
    [Abstract] [Full Text] [Related]

  • 5. The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6.
    Popovic V, Pekic S, Golubicic I, Doknic M, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 2002 May 30; 87(5):2095-9. PubMed ID: 11994347
    [Abstract] [Full Text] [Related]

  • 6. Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men.
    Van Dam PS, Smid HE, de Vries WR, Niesink M, Bolscher E, Waasdorp EJ, Dieguez C, Casanueva FF, Koppeschaar HP.
    J Clin Endocrinol Metab; 2000 Dec 30; 85(12):4706-11. PubMed ID: 11134132
    [Abstract] [Full Text] [Related]

  • 7. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2000 Jan 30; 85(1):183-92. PubMed ID: 10634385
    [Abstract] [Full Text] [Related]

  • 8. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD.
    Eur J Endocrinol; 1998 Jul 30; 139(1):59-71. PubMed ID: 9703380
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Catalina PF, Mallo F, Andrade MA, García-Mayor RV, Diéguez C.
    J Clin Endocrinol Metab; 1998 Oct 30; 83(10):3663-7. PubMed ID: 9768681
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
    Micić D, Macut D, Popović V, Kendereski A, Sumarac-Dumanović M, Zorić S, Dieguez C, Casanueva FF.
    Metabolism; 1999 Apr 30; 48(4):525-30. PubMed ID: 10206449
    [Abstract] [Full Text] [Related]

  • 11. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.
    Grugni G, Guzzaloni G, Morabito F.
    J Endocrinol Invest; 2001 May 30; 24(5):340-8. PubMed ID: 11407654
    [Abstract] [Full Text] [Related]

  • 12. Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test.
    Kelestimur F, Popovic V, Leal A, Van Dam PS, Torres E, Perez Mendez LF, Greenman Y, Koppeschaar HP, Dieguez C, Casanueva FF.
    Clin Endocrinol (Oxf); 2006 Jun 30; 64(6):667-71. PubMed ID: 16712669
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of growth hormone deficiency in adults by testing with GHRP-6 alone or in combination with GHRH: comparison with the insulin tolerance test.
    Petersenn S, Jung R, Beil FU.
    Eur J Endocrinol; 2002 May 30; 146(5):667-72. PubMed ID: 11980622
    [Abstract] [Full Text] [Related]

  • 14. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May 30; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 15. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A, Cerbone G, Pivonello R, Aimaretti G, Loche S, Di Somma C, Faggiano A, Corneli G, Ghigo E, Lombardi G.
    J Clin Endocrinol Metab; 1999 Apr 30; 84(4):1277-82. PubMed ID: 10199767
    [Abstract] [Full Text] [Related]

  • 16. Establishment of reference values for endocrine tests. Part VII: growth hormone deficiency.
    Eskes SA, Tomasoa NB, Endert E, Geskus RB, Fliers E, Wiersinga WM.
    Neth J Med; 2009 Apr 30; 67(4):127-33. PubMed ID: 19581656
    [Abstract] [Full Text] [Related]

  • 17. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F, Fernandez T, Martinez T, Peñalva A, Peinó R, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1998 Dec 30; 83(12):4350-4. PubMed ID: 9851776
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY, Granda-Ayala R.
    Endocrine; 2001 Feb 30; 14(1):79-86. PubMed ID: 11322505
    [Abstract] [Full Text] [Related]

  • 19. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 2000 Oct 30; 85(10):3693-9. PubMed ID: 11061526
    [Abstract] [Full Text] [Related]

  • 20. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P, Isidro L, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F.
    Clin Endocrinol (Oxf); 2002 Apr 30; 56(4):487-92. PubMed ID: 11966741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.